Hyperglycemia Induces Trained Immunity In Macrophages And Their Precursors And Promotes Atherosclerosis

This groundbreaking study from Oxford University researchers investigated why people with diabetes continue to have elevated heart disease risk even when their blood sugar is well-controlled with medication. They focused on a type of immune cell called macrophages, which play a key role in both immune responses and the development of atherosclerosis (hardening of the arteries).

The researchers discovered that when macrophages are exposed to high glucose levels, they undergo a process called "trained immunity" - essentially becoming reprogrammed to remain in a chronic inflammatory state. This inflammatory programming persists even after glucose levels return to normal, creating lasting changes in how these immune cells behave. The study used both mouse models and human tissue samples to demonstrate that this glucose-induced training makes macrophages more likely to promote atherosclerosis and cardiovascular disease.

The research team conducted sophisticated genetic analysis to understand exactly how high glucose rewires these immune cells at the molecular level. They found that the process depends on glycolysis (how cells process glucose for energy) and creates persistent changes in gene expression that favor inflammation and plaque formation in arteries.

This discovery helps explain the "metabolic memory" phenomenon - why cardiovascular risk remains elevated in diabetes patients even with good glucose control. For clinical practice, this research suggests that preventing hyperglycemic episodes early in diabetes management may be crucial for long-term cardiovascular health, and points toward potential new therapeutic targets focused on reversing this harmful immune cell reprogramming rather than just controlling blood sugar levels.